(Q38204263)

English

Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review

scientific article published on 11 April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

0 references

0 references

systematic review

1 reference

based on heuristic

inferred from title

object named as

Bontha V Babu

1

0 references

author name string

Gopalan R Babu

2

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

publication date

11 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

108

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

538-549

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Predictors of compliance with a mass drug administration programme for lymphatic filariasis in Orissa State, India 2008.

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Coverage and compliance to mass drug administration for lymphatic filariasis elimination in a district of Kerala, India

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Use of an inclusive-partnership strategy in urban areas of Orissa, India, to increase compliance in a mass drug administration for the control of lymphatic filariasis

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Mass drug administration for elimination of lymphatic filariasis: Recent experiences from a district of West Bengal, India

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Mass drug administration against filariasis in India: perceptions and practices in a rural community in Kerala

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

An evaluation of coverage and compliance of mass drug administration 2006 for elimination of lymphatic filariasis in endemic areas of gujarat

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Mathematical modelling and the control of lymphatic filariasis

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Situation analysis in a large urban area of India, prior to launching a programme of mass drug administrations to eliminate lymphatic filariasis

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Impact of the 2004 mass drug administration for the control of lymphatic filariasis, in urban and rural areas of the Western province of Sri Lanka.

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Delivery strategy of mass annual single dose DEC administration to eliminate lymphatic filariasis in the urban areas of Pondicherry, South India: 5 years of experience

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

The 6th Meeting of the Global Alliance to Eliminate Lymphatic Filariasis: A half-time review of lymphatic filariasis elimination and its integration with the control of other neglected tropical diseases

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Urban lymphatic filariasis

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Population migration: implications for lymphatic filariasis elimination programmes

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Increasing coverage in mass drug administration for lymphatic filariasis elimination in an urban setting: a study of Malindi Town, Kenya

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature.

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Adverse reactions following mass drug administration with diethylcarbamazine in lymphatic filariasis endemic areas in the Northeast of Brazil

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Mass treatment to eliminate filariasis in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Elimination of lymphatic filariasis: mass drug administration in endemic areas of (bidar district) karnataka-2008.

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Mass drug administration coverage evaluation survey for lymphatic filariasis in bagalkot and gulbarga districts

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Lymphatic filariasis elimination programme in Andaman and Nicobar Islands, India: drug coverage and compliance post eight rounds of MDA.

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Mass drug administration to eliminate lymphatic filariasis in Southern India

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRU057

21 January 2018

Identifiers

10.1093/TRSTMH/TRU057

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38204263&oldid=2158481066"